United European Gastroenterology Journal

Article	Citations
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations	131
Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta‐analysis	88
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutri	84
A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group	76
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis	71
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia	65
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility	60
Implications of the changing epidemiology of inflammatory bowel disease in a changing world	60
Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta‐analysis	53
Environmental risk factors for inflammatory bowel disease	50
European guideline on indications, performance and clinical impact of 13C‐breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC	47
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases	47
European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice	46
Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validation	46
New concepts in the treatment of hepatocellular carcinoma	45
Guideline for the diagnosis and treatment of Faecal Incontinence—A UEG/ESCP/ESNM/ESPCG collaboration	44
The gastrointestinal tract in hunger and satiety signalling	42
Inflammatory bowel disease and risk of severe COVID‐19: A nationwide population‐based cohort study in Sweden	42
Panenteric capsule endoscopy identifies proximal small bowel disease guiding upstaging and treatment intensification in Crohn's disease: A European multicentre observational cohort study	39
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study	38
The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries	35
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease	34
Current status and limitations of artificial intelligence in colonoscopy	32
Gut fermentation syndrome: A systematic review of case reports	31
UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better	31

Time trends in incidence and prevalence of chronic pancreatitis: A 25‐year population‐based nationwide study	29
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune‐mediated inflammatory diseases: A European retrospective observational study	27
A diagnostic delay of 10 years in the DanEoE cohort calls for focus on education ‐ a population‐based cross‐sectional study of incidence, diagnostic process and complications of eosinophilic oesophagi	27
Early treatment with anti‐tumor necrosis factor agents improves long‐term effectiveness in symptomatic stricturing Crohn’s disease	26
SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease	26
Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience	26
Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register	26
The global prevalence of Barrett’s esophagus: A systematic review of the published literature	25
Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure	25
The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies	25
Clinical management of patients with drug‐induced liver injury (DILI)	25
Worldwide prevalence and burden of gastroparesis‐like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on	25
Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials	24
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline	24
Effectiveness and safety of vedolizumab in biologically naïve patients: A real‐world multi‐centre study	23
A new artificial intelligence system successfully detects and localises early neoplasia in Barrett's esophagus by using convolutional neural networks	23
Eosinophilic oesophagitis in Denmark: Population‐based incidence and prevalence in a nationwide study from 2008 to 2018	23
Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population	22
Analysis of the burden and economic impact of digestive diseases and investigation of research gaps and priorities in the field of digestive health in the European Region—White Book 2: Executive summa	22
Close follow‐up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long‐term management of eosinophilic esophagitis	22
Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020	21
Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland	21
Gastroesophageal reflux after per‐oral endoscopic myotomy is frequently asymptomatic, but leads to more severe esophagitis: A case‐control study	21
Clinical management of the most common extra‐intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes	21
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis	21
Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry	20
Treat‐to‐target and sequencing therapies in Crohn's disease	20
Ulcerative colitis: Impact of early disease clearance on long‐term outcomes ‐ A multicenter cohort study	20
The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population‐based cohort study	19
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study	19
Management of pregnancy in women with cirrhosis	19
Mortality in acute pancreatitis with persistent organ failure is determined by the number, type, and sequence of organ systems affected	18
Cold versus hot polypectomy/endoscopic mucosal resection–A review of current evidence	18
Treatment outcomes of endoscopic submucosal dissection and surgery for colorectal neoplasms in patients with ulcerative colitis	18
COVID‐19 in gastroenterology: Where are we now? Current evidence on the impact of COVID‐19 in gastroenterology	18
Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease	18
Real‐time use of artificial intelligence (CADEYE) in colorectal cancer surveillance of patients with Lynch syndrome—A randomized controlled pilot trial (CADLY)	18
Epidemiology of pyogenic liver abscesses in Germany: Analysis of incidence, risk factors and mortality rate based on routine data from statutory health insurance	17
Landscape of new drugs and targets in inflammatory bowel disease	17
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis	16
The effectiveness of rotating versus single course antibiotics for small intestinal bacterial overgrowth	16
Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease: Results of the HOT‐TOPIC trial after 1‐year follow‐up	16
Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study	16
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme	16
Ultrasonography in inflammatory bowel disease – So far we are?	16
Risk of hepato‐pancreato‐biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population‐based cohort study	16
Gastrointestinal bleeding and endoscopic findings in critically and non‐critically ill patients with corona virus disease 2019 (COVID‐19): Results from Lean European Open Survey on SARS‐CoV‐2 (LEOSS)	15
Diagnostic accuracy of pan‐enteric capsule endoscopy and magnetic resonance enterocolonography in suspected Crohn's disease	15
Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population	15
Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease	15

Cold snare polypectomy for large sessile serrated lesions is safe but follow‐up is needed: a single‐centre retrospective study	15
Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community‐based cohort study	14
Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis—Results from the population‐based DanEoE cohort shows a low complication rate	14
Disorders of gut‐brain interaction: Highly prevalent and burdensome yet under‐taught within medical education	14
Indeterminate pediatric acute liver failure: Clinical characteristics of a temporal cluster of five children in the Netherlands in the spring of 2022	14
Influence of sex in alcohol‐related liver disease: Pre‐clinical and clinical settings	14
Endoscopic band ligation compared to thermal therapy for gastric antral vascular ectasia: A systematic review and meta‐analysis	13
Transmural remission improves clinical outcomes up to 5 years in Crohn's disease	13
High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort	13
Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis	13
German guideline diverticular disease/diverticulitis	13
The COlorectal NEoplasia Endoscopic Classification to Choose the Treatment classification for identification of large laterally spreading lesions lacking submucosal carcinomas: A prospective study of	13
UEG Week 2021 Poster Presentations	13
Faster and less invasive tools to identify patients with ileal colonization by adherent‐invasive E. coli in Crohn's disease	13
Crohn's disease related strictures in cross‐sectional imaging: More than meets the eye?	13
Barrett's esophagus surveillance in a prospective Dutch multi‐center community‐based cohort of 985 patients demonstrates low risk of neoplastic progression	13
Gastrointestinal bleeding in patients with pancreatic cancer: Causes and haemostatic treatments	13
Histologic parameter score does not predict short‐term survival in severe alcoholic hepatitis	13
Tumour‐stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case‐cohort study	13
Towards a robust and compact deep learning system for primary detection of early Barrett’s neoplasia: Initial image‐based results of training on a multi‐center retrospectively collected data set	13
Endoscopic direct clipping versus indirect clipping for colonic diverticular bleeding: A large multicenter cohort study	13
German guideline diverticular disease/diverticulitis	13
Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors	12
Unraveling the relationship between autoimmune pancreatitis type 2 and inflammatory bowel disease: Results from two centers and systematic review of the literature	12
How to raise the interest for neurogastroenterology among young gastroenterologists?	12
Sample‐size estimation is not reported in 24% of randomised controlled trials of inflammatory bowel disease: A systematic review	12
The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis	12
Gastrointestinal transit and contractility in diabetic constipation: A wireless motility capsule study on diabetes patients and healthy controls	12
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization	12
Creeping fat formation and interaction with intestinal disease in Crohn's disease	12
COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry	12
Post‐pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes	11
Development and evaluation of a deep learning model to improve the usability of polyp detection systems during interventions	11
High prevalence of extended‐spectrum beta‐lactamase organisms and the COVID‐19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong	11
Discrepancy between patient‐ and healthcare provider‐reported adverse drug reactions in inflammatory bowel disease patients on biological therapy	11
Gastric cancer detection by non‐blood‐based liquid biopsies: A systematic review looking into the last decade of research	11
Post‐polypectomy surveillance colonoscopy: Comparison of the updated guidelines	11
Adverse events in endoscopic retrograde cholangiopancreaticography (ERCP): Focus on post‐ERCP‐pancreatitis	11
UEG and EAES rapid guideline: Update systematic review, network meta‐analysis, CINeMA and GRADE assessment, and evidence‐informed European recommendations on surgical management of GERD	11
Therapeutic management of metabolic dysfunction associated steatotic liver disease	11
Glucose variability during the early course of acute pancreatitis predicts two‐year probability of new‐onset diabetes: A prospective longitudinal cohort study	10
Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review	10
Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany	10
Join the myUEG community and become an official myUEG Associate for free	10
Implementation of endoscopic submucosal dissection in a country with a low incidence of gastric cancer: Results from a prospective national registry	10
Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1	10
Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low‐risk tumours are not associated with lymph node metastases	10
Gut inflammation induced by drugs: Can pathology help to differentiate from inflammatory bowel disease?	10
A starch‐ and sucrose‐reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence varian	10
Standard versus Endocuff versus cap‐assisted colonoscopy for adenoma detection: A randomised controlled clinical trial	10
Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication thera	10
New endoscopic tools in inflammatory bowel disease	10
A global survey of health care workers' awareness of non‐alcoholic fatty liver disease: The AwareNASH survey	10
Endoscopic retrograde cholangiopancreatography‐related adverse events in Korea: A nationwide assessment	10
Oral health and salivary function in ulcerative colitis patients	10
Prevalence of COVID‐19 in patients with autoimmune liver disease in Europe: A patient‐oriented online survey	10
Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines–A cross‐sectional observational study	9
Plasma procalcitonin may be an early predictor of liver injury in acetaminophen poisoning: A prospective cohort study	9
Cost‐effectiveness of pancreas surveillance: The CDKN2A‐p16‐Leiden cohort	9
Ulcerative colitis increases risk of hypertension in a UK biobank cohort study	9
Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance	9
Morbid obesity increases death and dropout from the liver transplantation waiting list: A prospective cohort study	9
Young GI angle #Twitter2Paper: Taking an idea from Twitter to paper	9
Serum phosphate is associated with mortality among patients admitted to ICU for acute pancreatitis	9
Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0	9
Endoscopists performance in optical diagnosis of colorectal polyps in artificial intelligence studies	9
Prognosis of variceal and non‐variceal upper gastrointestinal bleeding in already hospitalised patients: Results from a French prospective cohort	9
Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies	9
High prevalence of ulcerative appendicitis in patients with ulcerative colitis	9
Celiac disease and risk of microscopic colitis: A nationwide population‐based matched cohort study	9
Effectiveness of first and second‐line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management	9
Factors influencing the outcome of vedolizumab treatment: Real‐life data with objective outcome measurements	9
Gut microbiota signatures in inflammatory bowel disease	9
Diversion proctocolitis and the problem of the forgotten rectum in inflammatory bowel diseases: A systematic review	9
Over‐the‐scope clip versus transcatheter arterial embolization for refractory peptic ulcer bleeding—A propensity score matched analysis	9
Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease	8
Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients	8
Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study	8
The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program	8
How to identify, encourage, and support suitable candidates for leading roles in scientific societies: The UEG experience	8

Increased Hepatitis C virus screening, diagnosis and linkage to care rates among people who use drugs through a patient‐centered program from Italy	8
Coeliac disease re‐screening among once seronegative at‐risk relatives: A long‐term follow‐up study	8
Barrett Esophagus: Quality of life and factors associated with illness perception	8
Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease	8
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis	8
Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease	8
AGREE‐S: AGREE II extension for surgical interventions – United European Gastroenterology and European Association for Endoscopic Surgery methodological guide	8
Clinical usefulness of scoring systems to predict severe acute pancreatitis: A systematic review and meta‐analysis with pre and post‐test probability assessment	8
Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort	8
Endoscopic management of duodenal adenomatosis in familial adenomatous polyposis—A case‐based review	8
COVID‐19 and digestive health: Implications for prevention, care and the use of COVID‐19 vaccines in vulnerable patients	7
New risk stratification after colorectal polypectomy reduces burden of surveillance without increasing mortality	7
Validation of stricture length, duration and obstructive symptoms as predictors for intervention in ileal stricturing Crohn's disease	7
The Workgroup Serrated Polyps and Polyposis (WASP) classification for optical diagnosis of colorectal diminutive polyps with iScan and the impact of the revised World Health Organization (WHO) criteri	7
Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease	7
Metabolic‐associated fatty liver disease is associated with acute pancreatitis with more severe course: Post hoc analysis of a prospectively collected international registry	7
A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome	7
A new path for the UEG Journal	7
Irritable bowel syndrome: Factors of importance for disease‐specific quality of life	7
Obesity and alcoholic etiology as risk factors for multisystem organ failure in acute pancreatitis: Multinational study	7
Acupuncture combined with ondansetron for prevention of postoperative nausea and vomiting in high‐risk patients undergoing laparoscopic gynaecological surgery: A randomised controlled trial	7
Global strategy for the diagnosis and management of acute kidney injury in patients with liver cirrhosis	7
Digestive cancer screening across Europe	7
Benign inheritable disorders of bilirubin metabolism manifested by conjugated hyperbilirubinemia–A narrative review	7